Anyone with significant medical conditions, anyone pregnant or breastfeeding, and anyone on multiple medications needs a careful review first not because problems are expected, but because limited human data means we don't assume
The differentiator is not the purity number
Doping: AFL chief Andrew Demetriou says status of drug AOD-9604 remains uncertain Fri 12 Jul 2013 at 6:07pm AFL chief executive Andrew Demetriou says doubts linger over the classification of AOD-9604, the drug which is a key element of the investigation into Essendon's use of supplements
Its human clinical trial history two separate trials with no reported toxicity further differentiates it from peptides studied only in animal models
growth hormone, insulin analogs), vaccines, and other parenteral drugs before administering them
Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase